Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the importance of using a clinically validated test such as the Breast Cancer IndexSM (BCI).
Weighing the value that emerging therapies have for improving outcomes and significantly impacting quality of life against the cost of care is a challenge for all stakeholders involved in managing patients with PV.
Listen as some of the top academic and community thought leaders in multiple myeloma define what precision medicine means to them.
The publishers of PMO invite you to watch an interview with Dr Lawrence Weiss, Medical Director at Clarient Diagnostic Services, discussing personalized medicine in diagnostics and with MultiOmyx™.
Highlights from the Third Annual World Cutaneous Malignancies Congress Conference in San Francisco, California
Highlights from the Third Annual PMO Live Conference, a Global Biomarkers Consortium Initiative, in San Francisco, California